5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Food and Drug Administration recommends against the continued use of propoxyphene.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Following receipt of a Citizens' petition, the Food and Drug Administration (FDA) convened an advisory committee to address the safety of propoxyphene. This led to a comprehensive review that culminated in a November 19, 2910, press release in which the FDA recommended against continued use of the drug. The FDA release contains a data summary (background), a safety announcement, additional Information for Patients, additional information for health care professionals, and references. All dosage forms of the drug have now been withdrawn from the United States market.

          Related collections

          Author and article information

          Journal
          J Pain Palliat Care Pharmacother
          Journal of pain & palliative care pharmacotherapy
          Informa UK Limited
          1536-0539
          1536-0288
          2011
          : 25
          : 1
          Article
          10.3109/15360288.2010.549553
          21426228
          2c597237-9c12-4872-8597-17bd2680924a
          History

          Comments

          Comment on this article